Table 3

Mean values for peak 1 min and 30 min cadences

ReferenceSampleInstrumentMonitoring framePeak 1 min cadence
(steps/min)
Peak 30 min cadence
(steps/min)
Gardner44
2007
98 participants with intermittent claudication (IC),
129 healthy controls matched for age, gender, race;
50–90 years (64±12 years for control group and 66±12 years for IC group)
StepWatch 3, Cyma, Mountlake Terrace, Washington1 week
  • IC 90.8±14.0*

  • Healthy 99.0±13.6*

  • IC 52.4±17.0*

  • Healthy 61.6±14.8*

Mudge48
2008
40 participants >6 months poststroke;
69.2±12.6 years
StepWatch Activity Monitor (Orthocare Innovations, Mountlake
Terrace, Washington)
Two 3-day periods, separated by 1 week
  • 81±25

  • 58±22

Gardner49 2008133 patients with intermittent claudication;
50–90 years (67±10 years)
StepWatch 3, Cyma, Mountlake Terrace, Washington1 week
  • 92.2±10.8*

  • 56.6±14.6*

Gardner21
2010
40 men, 41 women with peripheral artery disease limited by IC; men 66.3±10.0 years, women 64.1±10.9 yearsStepWatch 3 (Cyma, Mountlake Terrace, Washington)1 week
  • Men 94.4±11.4*,†

  • Women 86.2±11.4*

  • Men 62±15.4*, †

  • Women 52.6±15.4*, †

Mudge50
2010
30 healthy adults;
15 men, 15 women;
18–49 years (27.7±8.9 years)
StepWatch Activity Monitor (Orthocare Innovations, Mountlake Terrace, Washington)Two 3-day periods, separated by 1 week
  • 111.8±9.3

  • 82.3±12.7

Parker51
2010
27 community-dwelling participants with lower limb amputations, fit with prostheses for >1 year;
20–89 years (55.2±15.8 years)
Step Activity Monitor (SAM)1 weekNR
  • 48.6±22.2

Tudor-Locke5220123522 NHANES participants;
20+ years
ActiGraph 71641 week
  • Men 100.9

  • Women 100.5

  • 20–29 years 106.6

  • 30–59 years 104.3

  • 60–69 years 94.2

  • 70+ years 81.5

  • Men 73.7

  • Women 69.6

  • 20–29 years 76.8

  • 30–59 years 75.2

  • 60–69 years 65.2

  • 70+ years 52.6

Tudor-Locke25201254 healthy adults;
20 men, 34 women;
20–36 years (26.4±4.6 years)
ActiGraph GT1M1 weekNR
  • Total 81.5±25.9

  • Men 84.2±24.3

  • Women 79.9±27.0

Nguyen532012183 patients with cardiopulmonary illnesses: 63 patients (mean age of 67.0±9.3 years) with chronic obstructive pulmonary disease (COPD), 60 heart failure (60.5±10.8 years), and 60 implantable cardioverter defibrillator (55.4±11.6 years)StepWatch 3 Activity Monitor (SAM)1 week
  • Total 71±21

  • COPD 57±16

  • Heart failure 71±20

  • Cardiac dysrhythmias 85±18

Tudor-Locke23201315 community-dwelling older adults;
7 men, 8 women;
61–81 years (70.86±9.16 years for men and 67.38±4.31 years for women)
ActiGraph GT3X+1 week
  • Men 106.5±16.3

  • Women 96.7±19.7

  • Men 78.3±11.1

  • Women 67.9±26.0

Schuna 4*
2013
3725 NHANES participants;
1770 men, 1955 women;
20+ years
ActiGraph 7164 (ActiGraph, Pensacola, Florida)1 week
  • Total 100.8±36.6†

  • MVPA<150 min/wk 94.3±29.2†

  • MVPA≥150 min/wk 105.3±31.2†

  • UODA (Sit) 96.1±29.1†

  • UODA (SWLC) 102.2±32.2†

  • LTSB≥3 hours/day 97.4±39.7†

  • LTSB<3 hours/day 104.4±29.5†

  • Total 71.6±42.7†

  • MVPA<150 min/wk 64.0±25.0†

  • MVPA≥150 min/wk 76.8±44.6†

  • UODA (Sit) 65.9±35.0†

  • UODA (SWLC) 73.3±37.5†

  • LTSB≥3 hours/day 68.2±44.1†

  • LTSB<3 hours/day 75.2±33.8†

Schuna54
2013
143 community-dwelling, participants with no dementia;
43 men, 100 women;
58–92 years (71.9±7.9 years)
ActiGraph GT3X+1 weekNR
  • Total 63.6±24.6

  • Men 64.4±22.7

  • Women 63.3±25.5

Gardner22 2013250 healthy subjects;
45 metabolic syndrome (MS) group;
205 control group;
10–30 years (17.9±5.5 years for control group and 17.2±5.5 years for MS group)
StepWatch 3, Orthocare Innovations, Oklahoma City, Oklahoma1 week
  • Metabolic syndrome group 102.4±13.2*

  • Control group 110±12.6*

  • MS group 72.4±15.8*

  • Control group 81±16.8*

Gonzales55
2014
45 recreationally active young adults;
22 men, 23 women;
18–31 years (22±3 years)
ActiGraph GT3X+1 weekNR
  • 98±25

Gonzales56 201543 community-dwelling older adults;
18 men, 25 women;
60–78 years (67.3±5.3 years)
ActiGraph GT3X+1 weekNR
  • Total 77.0±27.3

  • Men 76.8±25.0

  • Women 77.2±29.5

Kang28
2016
1282 NHANES participants;
646 men, 636 women;
17+ years
ActiGraph 71641 week
  • Total 100.2±18.6

  • Men 99.9±16.4

    • Wkdays 101.2±17.2

    • Wkend 96.6±18.7

  • Women 100.4±20.6

    • Wkdays 101.5±21.6

    • Wkend 97.6±22.8

  • Total 71.2±28.7

  • Men 72.7±26.6

    • Wkdays 74.4±27.8

    • Wkend 68.5±29.0

  • Women 69.7±30.7

    • Wkdays 71.3±32.2

    • Wkend 65.8±33.0

Gonzales56
2015
43 older adults;
19 men, 24 women;
60–78 years
ActiGraph GT3X+1 week
  • Lower total daily step group (<7500 steps) 96.7±15.0

  • Higher total daily step group (>7500 steps) 123.1±16.8

  • Lower 1 min peak cadence group (<105 steps/min) 88.6±8.2

  • Higher 1 min peak cadence group (>105 steps/min) 121.5±14.4)

NR
Webber57 201770 older adults;
32 preoperative (11 men, 21 women, 69.9±5.3 years), 38 1-year postoperative participants with TKA (16 men, 22 women, 67.9±7.3 years)
ActiGraph GT3X+1 week
  • Preoperative 70.0±23.7

  • Postoperative 91.5±20.6

  • Preoperative 35.9 (19.3)‡

  • Postoperative 55.6 (31.0)‡

  • Tudor-Locke et al (2012) did not report SD values in their original article.

  • *Converted from reported strides/min by multiplying by2.

  • †SD determined by converting from reported SEs for means.

  • ‡Median (IQR).

  • LTSB, leisure time sedentary behaviour; MVPA, moderate-to-vigorous intensity physical activity; min/wk, minutes per week; NHANES, National Health and Nutrition Examination Survey; NR, not reported; sit, mostly sitting; SWLC, stand, walk, lift or carry; TKA, total knee arthroplasty; UODA, usual occupational/domestic activity; wkend, weekend; wkday, weekday.